Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBk. Cyprus Hldg Regulatory News (BOCH)

Share Price Information for Bk. Cyprus Hldg (BOCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 324.00
Bid: 320.00
Ask: 325.00
Change: 2.00 (0.62%)
Spread: 5.00 (1.563%)
Open: 320.00
High: 324.00
Low: 320.00
Prev. Close: 322.00
BOCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Changes in the Board Composition

28 Sep 2020 07:00

RNS Number : 2659A
Bank of Cyprus Holdings PLC
28 September 2020
 

Announcement

 

Changes in the Board Composition

 

Nicosia, 28 September 2020

 

 

Bank of Cyprus Holdings Public Limited Company ("BOC Holdings" and, together with its subsidiaries, the "Group") announces the departure of Dr Chris Patsalides from the position of First Deputy Chief Executive Officer ("FDCEO") and member of the Boards of BOC Holdings and Bank of Cyprus Public Company Limited (the "Boards"). Dr Patsalides will remain in office until 31 October 2020 in order to ensure smooth transition.

 

The Boards wish to express their thanks and deep appreciation to Dr. Patsalides for his dedication and exceptional service to the Group during his long career and wish him all the best for the future.

 

Mr Takis Arapoglou, Chairman of the Boards, commented:

 

"On behalf of the whole Board I wish to express our sincere thanks and gratitude to Chris for playing such a pivotal role over his 25 year tenure with the Group and more recently in the repair journey, helping the Bank to steadily regain its financial strength, with restored customer confidence."

 

Furthermore, the Boards decided to appoint Mr Constantine Iordanou as non-executive member of the Boards, and Mrs Eliza Livadiotou, Executive Director Finance, as executive member. Both appointments are subject to approval by the European Central Bank.

 

Mr Iordanou has been Chairman and Chief Executive Officer (CEO) of Arch Capital Group Limited, (Arch), since August 2003 and Director since January 2002 (retired in September 2019). Before joining Arch as one of its founders in 2002, Mr Iordanou served in various capacities for Zurich Financial Services ("Zurich") and its affiliates, including as Senior Executive Vice President of group operations and business development of Zurich Financial Services, President of Zurich-American Specialties Division, Chief Operating Officer and CEO of Zurich American, and CEO of Zurich North America. Before joining Zurich in March 1992, he was President of the commercial casualty division of the Berkshire Hathaway Group and Senior Vice President of American Home Insurance Company, a member of American International Group. Mr Iordanou currently serves as a director of Verisk Analytics and he is the Vice Chairman of NIPD Genetics. Mr Iordanou holds an Aerospace Engineering degree from New York University.

 

Mrs Livadiotou is the Executive Director Finance and is responsible for Financial Control, Treasury, Strategy and Corporate Finance, Investor Relations, Procurement and Economic Research. Mrs Livadiotou studied Economics at the University of Cambridge (MA Hons) on a Cambridge Commonwealth Trust scholarship. During 1995-1999, she worked for Arthur Andersen in Cambridge, where she qualified as a Chartered Accountant working in audit and transaction advisory. She joined Bank of Cyprus in 1999 and has served in a number of roles. In December 2013, she was appointed as Chief Financial Officer and in April 2016 as Finance Director.

 

 

 

Group Profile

 

The Bank of Cyprus Group is the leading banking and financial services group in Cyprus, providing a wide range of financial products and services which include retail and commercial banking, finance, factoring, investment banking, brokerage, fund management, private banking, life and general insurance. The Bank of Cyprus Group operates through a total of 98 branches in Cyprus, of which 14 operate as cash offices. Bank of Cyprus also has representative offices in Russia, Ukraine and China. The Bank of Cyprus Group employs 3,579 staff worldwide. At 30 June 2020, the Group's Total Assets amounted to €21.4 bn and Total Equity was €2.1 bn. The Bank of Cyprus Group comprises Bank of Cyprus Holdings Public Limited Company, its subsidiary Bank of Cyprus Public Company Limited and its subsidiaries.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAKKFBPPBKKNCB
Date   Source Headline
23rd May 20227:17 amRNSResolutions of AGM- Replacement
20th May 202212:36 pmRNSResolutions of AGM
19th May 20227:02 amRNSDoc re. (1Q2022 Financial Results Presentation)
19th May 20227:00 amRNS1st Quarter Results
5th May 20229:47 amRNSDate of announcement of 1Q2022 FR
14th Apr 20221:06 pmRNSNotice of AGM
13th Apr 202212:41 pmRNSPDMR Transaction - Ioardanou
7th Apr 202212:53 pmRNSPillar 3 Disclosures for 2021
4th Apr 20227:27 amRNSTR1 Notification of Major Holdings- Caius
30th Mar 202210:57 amRNSPDMR Notification of Transaction – Iordanou
30th Mar 20227:05 amRNSBOC Annual Financial Report 2021 Announcement
30th Mar 20227:03 amRNSBOCH Annual Financial Report 2021 Announcement
30th Mar 20227:02 amRNSDoc re. (FY2021 Investor Presentation)
30th Mar 20227:00 amRNSFY2021 Group Financial Results
18th Mar 202211:46 amRNSNotice of Results
17th Mar 20229:37 amRNSRestrictive measures and sanctions against Russia
7th Mar 20224:41 pmRNSSecond Price Monitoring Extn
7th Mar 20224:36 pmRNSPrice Monitoring Extension
21st Feb 20227:02 amRNSDoc re. Prelim FY2021 Investor Presentation
21st Feb 20227:00 amRNSFY2021 Prel. Group FR and MT Strategic Targets
18th Feb 20228:22 amRNSTR1 Major Holdings Notification -Senvest
8th Feb 20227:00 amRNSDate of announcement of Preliminary Results 2021
13th Jan 20224:40 pmRNSSecond Price Monitoring Extn
13th Jan 20224:35 pmRNSPrice Monitoring Extension
17th Dec 20211:22 pmRNSCompletion of a small-scale targeted VEP
16th Dec 202110:27 amRNSDate of Annual General Meeting
6th Dec 20217:43 amRNSEU-wide Transparency Exercise 2021
1st Dec 20217:00 amRNSDecision to call Tier 2 Capital Notes
30th Nov 202111:51 amRNSAppointment of New Director
30th Nov 202110:32 amRNSGroup Financial Results for 9M2021 - Replacement
30th Nov 20217:04 amRNSDoc re. (9M2021 Presentation Announcement)
30th Nov 20217:00 amRNSGroup Financial Results for 9M2021
19th Nov 20218:25 amRNSDate of Announcement of 9M2021 FR
15th Nov 20217:00 amRNSAgreement for sale of a portfolio of NPLs
8th Nov 20214:41 pmRNSSecond Price Monitoring Extn
8th Nov 20214:36 pmRNSPrice Monitoring Extension
29th Oct 20214:35 pmRNSPrice Monitoring Extension
8th Oct 202112:10 pmRNSBuyback of Tier 2 Capital Notes
7th Oct 202111:57 amRNSAppointment of New Director
30th Sep 20218:32 amRNSTR-1 Notification- Caius
16th Sep 20217:33 amRNSTR-1 Notification -Senvest
13th Sep 202112:00 pmRNSTR-1 Notification - Carval
9th Sep 20214:41 pmRNSSecond Price Monitoring Extn
9th Sep 20214:36 pmRNSPrice Monitoring Extension
8th Sep 20214:40 pmRNSSecond Price Monitoring Extn
8th Sep 20214:36 pmRNSPrice Monitoring Extension
7th Sep 20219:13 amRNSTR-1 Notification - Caius
1st Sep 20218:39 amRNSDoc re. (1H2021 Investor Presentation)
1st Sep 20217:27 amRNSHalf-year Report -4
1st Sep 20217:20 amRNSHalf-year Report -3

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.